HLA class I antigen abnormalities and immune escape by malignant cells

Author： Seliger B.   Cabrera T.   Garrido F.   Ferrone S.  

Publisher： Academic Press

ISSN： 1044-579X

Source： Seminars in Cancer Biology, Vol.12, Iss.1, 2002-02, pp. : 3-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Abbreviations used in this paper: APM, antigen processing machinery; β2m,β2microglobulin; bp, base pair; CTL, cytotoxic T lymphocytes; ER, endoplasmic reticulum; HC, heavy chain; HNSCC, head and neck squamous cell carcinoma; IFN, interferon; IL, interleukin; KIR, killing inhibitory receptors; LMP, low molecular weight proteins; LOH, loss of heterozygosity; mAb, monoclonal antibody; MHC, major histocompatibility complex; NK, natural killer; PA, proteasome activator; PCR, polymerase chain reaction; RCC, renal cell carcinoma; SCLC, small cell-lung carcinoma; TAA, tumor-associated antigens; TAP, transporter associated with antigen processing; TCR, T cell receptor; TNF, tumor necrosis factor; wt, wild-type.

Related content

Immune selective pressure and HLA class I antigen defects in malignant lesions

By Chang Chien-Chung   Ferrone Soldano  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 2, 2007-02 ,pp. : 227-236 (10)

Springer Publishing Company

Access to resources Recommend Favorite

HLA-I Antigen Presentation and Tapasin Influence Immune Responses Against Malignant Brain Tumors – Considerations for Successful Immunotherapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 8, 2014-10 ,pp. : 1094-1100 (7)

Bentham Science Publishers

Access to resources Recommend Favorite

HLA Class I Expression, Tumor Escape and Cancer Progression

By  

Current Cancer Therapy Reviews, Vol. 4, Iss. 2, 2008-05 ,pp. : 105-110 (6)

Bentham Science Publishers

Access to resources Recommend Favorite

The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape

By Algarra Ignacio   García-Lora Angel   Cabrera Teresa   Ruiz-Cabello Francisco   Garrido Federico  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 10, 2004-10 ,pp. : 904-910 (7)

Springer Publishing Company

Access to resources Recommend Favorite

Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations

By Aptsiauri Natalia   Carretero Rafael   Garcia-Lora Angel   Real Luis   Cabrera Teresa   Garrido Federico  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 11, 2008-11 ,pp. : 1727-1733 (7)

Springer Publishing Company

Access to resources Recommend Favorite